View Single Post
Old 01-03-2012, 10:30 PM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 19,725
CMS assigns J-code for Eisai's Halaven Injection to treat breast cancer

Eisai Inc. announced today that the Centers for Medicare and Medicaid Services (CMS) has assigned a unique, permanent Healthcare Common Procedure Coding System (HCPCS) J-code for Halaven (eribulin mesylate) Injection.

More...
News is offline   Reply With Quote